Shingles can cause severe chronic pain – new research on how exosomes alter neurons offers pathways to treatment
The reactivation of the varicella zoster virus decades after chickenpox can trigger shingles, a condition that, for a significant minority of patients, evolves into post-herpetic neuralgia—a form of chronic pain that resists treatment and devastates quality of life. New research implicates exosomes, microscopic vesicles circulating in the blood, as potential culprits in this neuropathic pain, suggesting that targeting these particles could unlock more effective therapies for a condition that currently leaves less than half of sufferers with meaningful relief.
What makes post-herpetic neuralgia particularly challenging to treat?
Post-herpetic neuralgia is notoriously difficult to manage because its underlying mechanisms remain poorly understood, leading to treatments that focus on symptom relief rather than addressing the root cause. Even antiviral therapies, which target the varicella zoster virus, fail to reliably prevent or reduce the condition, leaving patients with persistent pain that can last months to years and severely impact their well-being.
How do exosomes contribute to the development of post-herpetic neuralgia?
Exosomes—tiny vesicles released by cells that carry bioactive molecules—circulating in the blood of post-herpetic neuralgia patients appear to hinder the regeneration of sensory nerve fibers. Experiments showed that these exosomes suppress neuron growth and keep pain-sensing neurons in a hypersensitive state, preventing the repair of damaged nerve networks and perpetuating chronic pain.
Why is the varicella zoster virus’s reactivation decades after initial infection a public health concern?
The varicella zoster virus, which causes chickenpox, lies dormant in neurons after the initial infection and can reactivate decades later as shingles. While most cases resolve, a subset progresses to post-herpetic neuralgia, a condition that disproportionately affects older adults and is associated with significant declines in quality of life, including emotional distress and suicidal ideation.
What gaps remain in understanding the role of exosomes in post-herpetic neuralgia?
While research has identified exosomes as potential contributors to post-herpetic neuralgia, it is unclear exactly which molecular cargo within these vesicles is most responsible for nerve damage and pain. Further studies tracking exosomes over time in patients with shingles—those who develop chronic pain and those who do not—are needed to pinpoint the specific factors driving this debilitating condition.
Ce que ça pourrait changer
This research could shift the paradigm for treating post-herpetic neuralgia by shifting focus from viral suppression to targeting the cellular communication pathways mediated by exosomes. If exosomes prove to be a common mechanism in other neuropathic pain conditions, such as diabetic neuropathy, the findings could open avenues for broader therapeutic innovations in chronic pain management, potentially improving outcomes for millions of patients worldwide.
